153 related articles for article (PubMed ID: 25997472)
1. Intestinal Surgery for Crohn's Disease: Role of Preoperative Therapy in Postoperative Outcome.
Scarpa M; Martinato M; Bertin E; Da Roit A; Pozza A; Ruffolo C; D'Incà R; Bardini R; Castoro C; Sturniolo GC; Angriman I
Dig Surg; 2015; 32(4):243-50. PubMed ID: 25997472
[TBL] [Abstract][Full Text] [Related]
2. Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's disease.
El-Hussuna A; Andersen J; Bisgaard T; Jess P; Henriksen M; Oehlenschlager J; Thorlacius-Ussing O; Olaison G
Scand J Gastroenterol; 2012 Jun; 47(6):662-8. PubMed ID: 22486168
[TBL] [Abstract][Full Text] [Related]
3. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
4. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
Kotze PG; Saab MP; Saab B; da Silva Kotze LM; Olandoski M; Pinheiro LV; Martinez CA; Ayrizono ML; Magro DO; Coy CS
Dig Dis Sci; 2017 Feb; 62(2):456-464. PubMed ID: 27933472
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
Syed A; Cross RK; Flasar MH
Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
[TBL] [Abstract][Full Text] [Related]
7. Does preoperative immunosuppression influence unplanned hospital readmission after surgery in patients with Crohn's disease?
White EC; Melmed GY; Vasiliauskas E; Dubinsky M; Ippoliti A; McGovern D; Targan S; Fleshner P
Dis Colon Rectum; 2012 May; 55(5):563-8. PubMed ID: 22513435
[TBL] [Abstract][Full Text] [Related]
8. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
Rosenfeld G; Qian H; Bressler B
J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
[TBL] [Abstract][Full Text] [Related]
9. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery.
Kasparek MS; Bruckmeier A; Beigel F; Müller MH; Brand S; Mansmann U; Jauch KW; Ochsenkühn T; Kreis ME
Inflamm Bowel Dis; 2012 Jul; 18(7):1207-13. PubMed ID: 21928373
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy does not increase operative morbidity in patients with Crohn's disease.
Bafford AC; Powers S; Ha C; Kruse D; Gorfine SR; Chessin DB; Bauer JJ
J Clin Gastroenterol; 2013 Jul; 47(6):491-5. PubMed ID: 23090048
[TBL] [Abstract][Full Text] [Related]
11. Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates?
Canedo J; Lee SH; Pinto R; Murad-Regadas S; Rosen L; Wexner SD
Colorectal Dis; 2011 Nov; 13(11):1294-8. PubMed ID: 20969715
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.
Kanazawa A; Yamana T; Okamoto K; Sahara R
Dis Colon Rectum; 2012 Sep; 55(9):957-62. PubMed ID: 22874602
[TBL] [Abstract][Full Text] [Related]
13. Can POSSUM accurately predict post-operative complications risk in patients with abdominal Crohn's disease?
Ugolini G; Montroni I; Rosati G; Ghignone F; Bacchi-Reggiani ML; Belluzzi A; Castellani L; Taffurelli M
ANZ J Surg; 2014; 84(1-2):78-84. PubMed ID: 23796357
[TBL] [Abstract][Full Text] [Related]
14. Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide Cohort.
Brouquet A; Maggiori L; Zerbib P; Lefevre JH; Denost Q; Germain A; Cotte E; Beyer-Berjot L; Munoz-Bongrand N; Desfourneaux V; Rahili A; Duffas JP; Pautrat K; Denet C; Bridoux V; Meurette G; Faucheron JL; Loriau J; Guillon F; Vicaut E; Benoist S; Panis Y;
Ann Surg; 2018 Feb; 267(2):221-228. PubMed ID: 29300710
[TBL] [Abstract][Full Text] [Related]
15. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2013 Jan; 37(2):214-24. PubMed ID: 23190161
[TBL] [Abstract][Full Text] [Related]
17. Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.
Shental O; Tulchinsky H; Greenberg R; Klausner JM; Avital S
Dis Colon Rectum; 2012 Nov; 55(11):1125-30. PubMed ID: 23044672
[TBL] [Abstract][Full Text] [Related]
18. Side-to-side stapled anastomosis strongly reduces anastomotic leak rates in Crohn's disease surgery.
Resegotti A; Astegiano M; Farina EC; Ciccone G; Avagnina G; Giustetto A; Campra D; Fronda GR
Dis Colon Rectum; 2005 Mar; 48(3):464-8. PubMed ID: 15719193
[TBL] [Abstract][Full Text] [Related]
19. Surgery for intestinal Crohn's disease recurrence.
Brouquet A; Blanc B; Bretagnol F; Valleur P; Bouhnik Y; Panis Y
Surgery; 2010 Nov; 148(5):936-46. PubMed ID: 20363010
[TBL] [Abstract][Full Text] [Related]
20. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
Lightner AL; McKenna NP; Tse CS; Raffals LE; Loftus EV; Mathis KL
Aliment Pharmacol Ther; 2018 Mar; 47(5):573-580. PubMed ID: 29250800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
